Delhi High Court opposed Centre’s COVID-19 Protocol On Remdesivir.
The Delhi High Court on Wednesday opposed a “change” by the Center in the Covid treatment protocol related to the use of Remdesivir amid the drug shortage, saying “it seems you want people to die. “.
“This is wrong. This is a complete non-application of the mind. Now people who do not have oxygen will also not receive Remdesivir.”
“It seems he wants people to die,” Judge Prathiba M Singh said after the central government declared that, according to the protocol now being followed, Remdesivir was only administered to patients on oxygen support.
The court also said it will consider later whether a medical committee should review whether the protocols or guidelines for administering Remdesivir need any modification.
“Do not change the protocol just to reduce the shortage. That is wrong. As a result, doctors cannot prescribe Remdesivir,” the court said, adding: “This is complete mismanagement.”
On the allocation of the drug to Delhi, the Center told the court that more than 52,000 vials, out of the allocated amount of 72,000, were shipped to the national capital as of April 27.
He said the allocation was being made based on a state’s actual caseload.
However, the court said the allocation cannot be that low for Delhi.
The court also said it was “shocking” that a deputy could get 10,000 vials of the drug in Delhi, transport it to Ahmednagar in Maharashtra on a chartered flight and distribute it there.
“This scandalizes the conscience of the court. There are 10,000 vials that could have been given to patients in Delhi. There is complete mismanagement of the fee that the state is receiving,” he said.
Then the Center said that in the next few days the allocation would increase as there would be an increase in production.
The Delhi government, represented by additional permanent attorney Anuj Aggarwal, said it received only 2,500 vials of the more than 52,000 sent to the national capital.
When the court inquired about the remaining nearly 50,000 vials, it was reported that they were distributed through private channels to hospitals and patients.
The Delhi government thereafter told the court that in view of the private distribution of the drug, it decided to create a portal only through which hospitals could purchase the drug.
However, the court disagreed with the proposed system, saying that many people who need the drug are not hospitalized due to a lack of beds or are receiving treatment at home.
Judge Singh said the best option would be to allow the patient, family, or assistant to place the application on the drug portal, and then the person can pick it up from the hospital after making the payment.
The court said this will ensure that 90 percent of patients who need Remdesivir receive the drug, while if only hospitals administered the drug, only about 50 percent of patients would receive it.
It ordered the Delhi government to postpone launching the portal until suggestions made by the court are incorporated into it.
The court was hearing a guilty plea from a lawyer suffering from COVID-19 and was only able to obtain three of the required six doses of Remdesivir.
Due to court intervention, the attorney received the remaining vials on Tuesday evening.
The court had observed Tuesday that several companies in India were manufacturing the drug and that millions of vials of the drug should have been exported, “but we don’t have enough to care for our own patients.”
(Except for the headline, this story has not been edited by NewsGater staff and is posted from a syndicated feed.)